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The immune response to the synthetic random terpolymer of L-glutamic acid6°-L  - 
alanine3°-L-tyrosine 1° (GAT)1 is under the control of an autosomal dominant immune 
response  (Ir)  gene(s)  that  maps to the I-A region of the H°2 complex (1-3).  Mice of 
the H-2  p'q's haplotypes are genetic nonresponders to GAT: these mice fail to develop 
an antibody response after stimulation  with soluble GAT, but develop a  population 
of antigen-specific  genetically unrestricted  suppressor T  cells  (Ts cells)  that suppress 
GAT-specific  plaque-forming  cell  (PFC)  responses  (2,  3).  Mice  of all  other  H-2 
haplotypes are genetic responders and develop a  PFC response after stimulation with 
soluble GAT (1-3). GAT-specific Ts (GAT-Ts)  cells also have been demonstrated  in 
responder mice, but only under certain conditions:  (a) after stimulation of T  cells in 
vitro with soluble GAT in cultures extensively depleted of macrophages (M~)  (4); (b) 
after administration of high concentrations of GAT in vivo (5); and (c) after priming 
with  allogeneic GAT-M4~ in vivo and stimulation  with syngeneic GAT-Mq~ in vitro 
or, conversely, after priming with syngeneic GAT-Mq~ in  vivo and stimulation  with 
allogeneic GAT-Mq~ in vitro (6). In the latter situation genetically restricted helper T 
cell populations  that  functioned preferentially  when stimulated  with GAT-Mq~ syn° 
geneic to those Mq~ used for in vivo immunization were also defined  (6,  7). 
The  studies  reported  here  were  initiated  to  determine  the  effects  of injection  of 
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neonatal responder mice with syngeneic GAT-M~ on the subsequent response patterns 
of adult T  cells, especially the response patterns of the genetically restricted helper T 
cells.  We anticipated  that  the  generation of these helper T  cells  in adults  would be 
affected by exposure to GAT-Mq5 during the neonatal period. However, we obtained 
results  contrary  to our expectations:  injection  of syngeneic GAT-M~  into  neonates 
generated  a  population  of GAT-specific,  genetically  restricted  Ts  cells  (GAT-TsR 
cells). In this paper we describe the properties of these GAT-TsR cells, as well as those 
of the conventional and hybridoma-derived GAT-specific suppressor factors produced 
by these  cells  that  mediate  their  effects.  Finally,  these  GAT-specific Ts  cell  factors 
from responder mice (GAT-TsFR) are compared with GAT-specific suppressor factors 
derived from nonresponder mice (GAT-TsF)  (8-13). 
Materials  and Methods 
Mice.  C57Bl/10  (BI0),  B10.D2,  B10.A,  B10+BR, BALB/c, and  (B10  X  B10.D2)F1  mice 
were bred in the Animal Resources Facility of The Jewish Hospital of St. Louis, St. Louis, MO. 
BI0.A(5R) and  B10.A(4R)  mice were provided by Dr.  D.  Shreffler (Washington University 
School of Medicine,  St.  Louis,  MO);  BI0.A(3R)  mice were  provided  by Dr. J.  Stimpfling 
(McLaughlin  Research  Institute,  Great  Falls,  MT).  Mice  were  maintained  on  water  and 
laboratory chow ad libitum and used at  10  20 wk of age. 
Antigens,  GAT (-45,000 mol wt; Vega Biochemicals, Tucson, AZ) was prepared as previ- 
ously described for use as antigen in culture  (1), preparation of GAT-M~ (6,  7), coupling to 
sheep erythrocytes (SRBC) for use as indicator cells in the hemolytic plaque assay (1), and for 
in vivo immunization (1), GAT was complexed to methylated bovine serum albumin (MBSA) 
as previously described (1). SRBC (Colorado Serum Co., Denver, CO) were prepared for use as 
antigen in culture and as indicator cells in the hemolytic plaque assay as described previously 
(14). 
Antisera, Monoclonal Antibodies, andImmunoadsorbents.  BI0.D2 anti-B10 (anti-H-2b), (BI0.A X 
B10)Ft  anti-B10.D2  (anti-KABJEa),  (B10.A  ×  A)Ft  anti-B10.A(5R)  (anti-KABb),  [A.TL  X 
B10.S(9R)]F1  anti-B10.HTF  (anti-J~),  and  B10.A(5R)  anti-B10.A(3R)  (anti-J  b)  alloantisera 
were provided by Dr. D. Shreffler.  (B10.MBR X A/Sn) anti-B 10.A(5R)  (anti-I-ALb)  was provided 
by Dr. C+ David (Mayo Medical Schools, Rochester, MN)/, The hybridoma-derived monoclonal 
reagents,  WF9.40.5  [B10.A(5R)  anti-B10.A(3R)]  (anti-J)  and  WF8.C12.8  [B10.A(3R)  anti- 
B 10.A(5R)]  (anti-J k) were provided by Dr. C. Waltenbaugh (Northwestern University, Evans- 
ton, IL) (15). Monoclonal anti-I-A  a (MKD6) was provided by Dr. P. Marrack (National Jewish 
Hospital, Denver, CO). The anti-idiotype immunoadsorbent made from guinea pig anti-mouse- 
anti-GAT antibody  (anti-cGAT)  was  provided by  Dr.  M.  Dorf (Harvard  Medical  School, 
Boston, MA) (12). Rabbit anti-mouse IgG and anti-GAT antibodies were prepared as described 
by Thfize et  al.  (10).  The immunoglobulin fractions of the heat-inactivated  antisera  or the 
culture supernatant  fluids containing monoclonal antibodies were used to prepare Sepharose 
immunoadsorbents  (Sigma  Chemical  Co.,  St.  Louis,  MO)  according to the  manufacturer's 
instructions  (10,  12). GAT-, L-glutamic acidS°-tyrosine 5°- (GT), L-glutamic acidS°-L-alanine ~°- 
(GA), and bovine serum albumin-  (BSA)  Sepharose were provided by Dr. J.  Kapp.  Peanut 
agglutinin (PNA) agarose was purchased from E-Y Laboratories, San Mateo, CA. 
Monoclonal anti-Thy-1 was derived from the hybridoma T-24/40.7 obtained from the Salk 
Institute, La Jolla, CA. Monoclonal noncytotoxic anti-Lyt-1 was derived from hybridoma 7.313 
obtained  from Dr.  N.  Warner,  then  at  the  University of New  Mexico,  Albuquerque,  NM+ 
Arsinilate conjugates of monoclonal anti-Lyt-1 (clone 53.7.3;  lot B0302)  and anti-Lyt-2 (clone 
53.6.7; lot B0301), and rabbit anti-arsinilate (anti-Ars)  (lot C0401) were purchased from Becton, 
Dickinson & Co.  (Mountain View, CA). Prescreened rabbit complement  (C)  was purchased 
from Cedarlane Laboratories, Div. Accurate Chemical and Scientific Corp., Westbury, NY. 
Preparation of Cell  Populations.  Peritoneal-exudate  cells  collected  from  mice  injected  4  d 
previously with  1 ml of 10% proteose peptone were used as M¢~; M~ were pulsed with GAT as 
previously described (6, 7). T cells were separated from spleen cell suspensions by passage over 
nylon wool columns (16). Alternatively, spleen cell suspensions at 10 ×  l0  s cells/ml were reacted CRAIG M.  SORENSEN AND CARL W.  PIERCE  1693 
in plastic dishes coated with rabbit anti-mouse immunoglobulin (RaMIg) (5 ~tg/ml); after 60 
min at 4°C the nonadherent population was collected by aspiration and used as T cells (17). In 
one experiment T cells at 10 ×  106 cells/ml were reacted with monoclonal anti-Lyt-1 (7.313) at 
2 ~g/ml for 30 rain at 4°C and then fractionated on plastic plates coated with goat anti-rat 
immunoglobulin (5  /~g/ml);  nonadherent cells  (Lyt-1-)  were  collected  by  aspiration  and 
adherent cells  (Lyt-1 +)  were recovered by vigorous pipetting. Spleen cells were treated with 
monoclonal anti-Thy-1 (T-24/40.7; 1:50 dilution) and C diluted 1:12 for 45 rain at 37°C and 
used as T cell-depleted spleen cells. Spleen cells or T cells separated on RaMIg plates at  10 × 
106 cells/ml were reacted with the desired anti-I region antibody (1:50 dilution) for 30 min at 
4°C, washed, and incubated with C  (i: 12 dilution) for 45 min at 37°C. Alternatively, these 
cells were reacted sequentially with the desired arsinilate-conjugated  anti-Lyt reagent followed 
by  rabbit  anti-Ars antibody.  The  reagents  were  diluted  according  to  the  manufacturer's 
instructions; each reaction was for 30 rain at 4°C. Cells were then washed, resuspended at 5 
×  106 cells/ml in C diluted 1:12 in medium, and incubated for an additional 45 min at 37°C. 
The remaining cells were washed twice with medium and adjusted to 10 ×  106 viable cells/ml 
before addition to culture. 
Immunizations.  Neonatal B10  mice received  10  ×  106-15 ×  106 syngeneie Mff,  syngeneic 
GAT-M~ that bore 50-100 ng GAT/106 cells, or 10/lg soluble GAT via the orbital branch of 
the anterior facial vein within 18 h of birth (18). The ability of spleen cells from these mice to 
develop an in vitro PFC response to GAT was analyzed at  10-20 wk of age. Adult B10 mice 
were immunized by intraperitoneal injection of 10 btg GAT in Maalox-pertussis (1)  (Maalox: 
W. H. Roher, Inc., Ft. Washington, PA.; pertussis: Eli Lilly and Co., Indianapolis, IN.). 
Culture System and Hemolytic Plaque Assay.  Single cell  suspensions of spleen in completely 
supplemented Eagle's minimum essential medium with 10% fetal calf serum (lot 49502; Reheis 
Chemical Co.,  Kankakee, IL) were incubated at 5 X  10  ~ cells in 0.5 ml in 16-ram wells of 24- 
well  tissue  culture plates  (76-033-05;  Linbro Chemical  Co.,  Div.  Flow  Laboratories,  Inc., 
Hamden, CT) for 5 d at 37°C in an atmosphere of 10% COz, 7% O2, and 83% N2 (1, 6). At the 
initiation of culture 3 ×  104 GAT-Mff that bore 5-10 ng GAT/105 cells, 2/Lg soluble GAT, 
GAT-MBSA containing 2/~g GAT, or 107 SRBC were added to the spleen cells. GAT-specific 
IgG, and IgM and IgG anti-SRBC PFC responses were assayed on day 5 of culture by the slide 
modification of the Jerne hemolytic plaque assay (1, 6, 14). Data are expressed  as PFC/culture. 
Preparation of GAT-TsFR.  Spleen  cells  from  control  B10  mice  or  B10  mice  injected as 
neonates with B 10 GAT-M~ were incubated at 5 ×  106 cells/well with 3 ×  104 syngeneic GAT- 
Mff for 24 h under the culture conditions described above. Supernatant fluids were collected, 
cleared of cellular debris by centrifugation, filtered through 0.20-#m filters  (Medical Device 
Division, Gelman Sciences,  Inc., Ann Arbor,  MI),  assayed  for suppressive activity in PFC 
responses  to GAT, and stored at -80°C. Some culture supernatant fluids were concentrated 
10-fold by ultrafihration using a YM10 filter (Amicon Corp., Lexington, MA) and applied to 
a  Sephacryl S-200 column equilibrated with isotonic phosphate buffer, pH  7.2. Appropriate 
fractions were collected, filtered, and assayed for suppressive activity in PFC responses to CAT. 
Generation of T Cell Hybridomas.  Spleen cells (5 X 106/well) from B I0 mice injected with B 10 
GAT-M~ as neonates were cultured with 3 ×  104 BI0 GAT-M~b for 24 h as described above; 
these cells containing  activated GAT-Tsa cells were harvested and fused with the hypoxanthine- 
guanine phosphoribosyl  transferase-deficient AKR  thymoma,  BW5147,  using polyethylene 
glycol (12, 19). The fused cells were cultured in hypoxanthine-aminopterin-thymidine  selection 
medium (12, 19,  20)  and scored for growth after 3-6 wk.  Cells from primary wells showing 
growth that  yielded supernatant fluids causing >75% specific  suppression PFC responses  to 
GAT by B10 spleen cells  were  cloned by limiting-dilution in soft  agar over 3T3 cell  feeder 
layers (12, 19). Individual colonies were expanded, and supernatant fluids were retested for 
GAT-specific suppressive activity. The hybridomas to  be discussed,  372.D6.5  and 372.B3.5, 
have  been  maintained in  tissue  culture  for  >12  mo  without  loss of activity,  and  active 
hybridoma cells have been recovered after freezing in liquid nitrogen. Supernatant fluids from 
BW5147 and cells from other wells of the same fusion (e.g., 372.B3.6) were consistently  negative 
for  either GAT-TsFa activity or  nonspecific suppressive activity.  Supernatant fluids were 
processed  as previously described for conventional  GAT-TsFR. 1694  SUPPRESSOR  T  CELLS  AND  FACTORS IN  RESPONDER  MICE 
Results 
Immune Responses by Spleen Cells from Neonatally  Treated Mice.  Spleen cells from  B10 
mice injected as neonates with B 10-M~ developed significant responses when stimu- 
lated with soluble GAT, GAT-MBSA, and syngeneic B10 or allogeneic B10.D2  and 
B10.BR  GAT-M~  (Table  I).  By  contrast,  spleen cells from  B10  mice  injected with 
B10  GAT-M~  as neonates  responded  to GAT  presented on  allogeneic B10.D2  and 
B10.BR  Mq~, but  failed to respond to soluble GAT, GAT-MBSA, or syngeneic B10 
GAT-M~  and  had  significantly  reduced  responses  to  GAT  presented  on  (B10  × 
B 10.D2)F1  M~.  A  similar pattern of responses was  demonstrated  in C57BI/10  mice 
injected as neonates with soluble GAT and in BALB/c mice injected as neonates with 
soluble GAT  or  BALB/c  GAT-M~.  In  neonatally treated  BALB/c  mice  responses 
were stimulated by allogeneic B10  and B10,BR  GAT-M4~, but not by soluble GAT, 
GAT-MBSA, or BALB/c GAT-Mq~ (data not shown). In all experiments, responses to 
SRBC  by spleen cells from  neonatally treated mice were  similar in  the presence or 
absence of GAT-M~  from the panel of M4~ used. 
Demonstration of Suppressor Cells in Neonatally  Treated Mice.  Spleen  cells from  neo- 
natally  treated  mice  responded  to  allogeneic GAT-Mdp,  suggesting  that  the  GAT- 
specific B cell populations were intact. The possibility that active suppression was the 
basis for the inability of spleen cells from neonatally treated mice to respond to soluble 
GAT or syngeneic GAT-M~ was investigated. Spleen cells or nylon wool-nonadherent 
spleen  cells  (T  cells)  from  B10  mice  injected  as  neonates  with  syngeneic  B10  M+ 
(control) or B 10 GAT-Mq~ (treated) were added to normal B 10 spleen cells in cultures 
stimulated with  a  panel  of GAT-M~  (Table II).  Responses  were  unaffected  by the 
addition of spleen cells or T  cells from mice injected as neonates with B10 M~. Spleen 
TABLE  I 
Primary In Vitro PFC Responses by Spleen Cells From Neonatally Treated 
Mice 
Antigens and M4~ in culture* 
Day-5 PFC/culture~: 
Spleen cells 
Control§  Treated§ 
GAT  470  28 
GAT-MBSA  458  <10 
B10 GAT-M~  425  53 
B10.D2 GAT-Mq,  488  478 
B 10.BR GAT-M~  410  420 
(B10 × B10.D2)F1 GAT-M~  583  190 
SRBC  3,450  3,330 
SRBC + BI0 GAT-M~  4,500  3,150 
SRBC + B10.D2 GAT-Mep  5,500  3,630 
* Spleen cells (5 x  106) were cultured with 2 ~g soluble GAT; GAT-MBSA 
containing 2/Lg GAT; 3 x  10  4 GAT-M~ from the indicated strain that bore 
5  10 ng GAT/10  '~ cells; 107 SRBC; or 107 SRBC +  3 X 104 GAT-Mdo  from 
the indicated strain. 
:~ IgG GAT-specific PFC/culture: IgM PFC/culture vs. SRBC in those cuhures 
stimulated by SRBC with or without GAT-Mq~. 
§Control, spleen cells from BI0  mice  injected  with  BI0  M~  as  neonates; 
treated, spleen cells fi'om BI0 mice iniected with B10 GAT-Mdp  as neonates. CRAIG M.  SORENSEN  AND CARL W.  PIERCE  1695 
TABLE II 
Suppression of PFC Responses by Virgin B I O Spleen Cells by Cells from Neonatally Treated B I O Mice 
Day-5 IgG GAT-specific PFC/culture* 
GAT-M~p  B 10 spleen  Control§  Treated§ 
cells:~  Spleen  T cells  Spleen  T cells 
B10  595  580  445  55  36 
B10.BR  410  410  450  443  457 
B10.D2  580  570  500  565  510 
B10 + SRBC  3,75011  3,33011  3,63011  3,45011  3,53011 
* B10 spleen cells (5 X 106) were cultured with 3 X  10  4 GAT-M4~ of the indicated strains bearing 4-5 ng 
GAT/10  5 cells. 
Responses by B10 spleen cells to the GAT-M~ in the absence of additional spleen or T cells. 
§ Control, B l0 mice injected as neonates with B10-Mth; treated, B 10 mice injected with B10 GAT-Mth as 
neonates. Spleen cells: 106/culture; nylon wool-nonadherent spleen cells (T cells): 105/cuhure. 
]] IgM PFC response to SRBC in BI0 spleen cell cultures stimulated with B10 GAT-Mth and  10  7 SRBC. 
cells or T  cells from  mice injected as neonates with  B10  GAT-Mtk did not  alter the 
responses  to  B10.D2  or  B10.BR  GAT-M~,  but  106  spleen  cells  or  105  T  cells 
significantly suppressed responses to B 10 GAT-Mth and to GAT or GAT-MBSA  (data 
not  shown).  Suppression was  antigen specific, and  no  significant suppression of the 
response to SRBC was observed even when B10 GAT-Mth were present in culture. 
Characterization  of the Suppressor  Cells.  Suppression of the PFC response to GAT by 
spleen cells from neonatally treated mice was mediated by a  nylon wool-nonadherent 
cell (Table II) which was also nonadherent  to RaMIg-coated plates (Table III). The 
suppressor cell was sensitive to treatment with anti-Thy- 1 4- C  and 500 rad irradiation. 
Significant suppression  (-50%)  of PFC responses by spleen cells stimulated with B10 
GAT-Mth was observed with as few as  104 Ts cells (data not shown). 
The Lyt phenotype and expression of Ia antigens by Ts cells were determined by 
assessing the ability of Ts cells to suppress PFC responses after treatment with either 
anti-Lyt antisera or anti-I region antisera and  C.  T  cells from  B10  mice injected as 
neonates with  B 10 Mff failed to suppress PFC responses and were not characterized 
further. Treatment of Ts cells from B10 mice injected as neonates with B10 GAT-Mth 
with arsinilate-conjugated anti-Lyt-1 and anti-Ars +  C, anti-Ars +  C, anti-I-J  k +  C, 
anti-LA  b 4- C,  and anti-I-A  d 4- C  failed to abolish the suppressive capacity of these 
cells (Table III). Treatment  with  arsinilate-conjugated anti-Lyt-2 and  anti-Ars +  C 
or  anti-I-J  b  4-  C  destroyed  the  ability of these  Ts  cells to  suppress  PFC  responses. 
Lastly, Ts cells, collected as nonadherent cells from RaMIg  plates, were subsequently 
reacted with noncytotoxic anti-Lyt-1 (7.313)  and separated on the basis of adherence 
to plates coated with goat anti-rat immunoglobulin;  as few as  104 nonadherent  (Lyt- 
1-) cells suppressed GAT-specific PFC responses stimulated by B 10 GAT-M4~, whereas 
adherent  (Lyt-1 +)  cells failed to suppress  these responses  (Table  III, experiment  3). 
Collectively, these results demonstrated the Ts cells were Lyt-1-2  +, I-J+,I-A  -. 
The kinetics of suppression was examined by adding Ts cells activated by incubation 
with BI0 GAT-Mt  h or B10.BR GAT-Mt  h for 24 h to virgin B10 spleen cells stimulated 
with 2 ~g GAT or SRBC.  The Ts cells activated by BI0 GAT-Mth, but not  B10.BR 
GAT-Mth, must be present during the first 24 h  of culture for significant suppression 
of responses to GAT  (Table IV). Activated Ts cells had no significant effect on PFC 1696  SUPPRESSOR  T  CELLS  AND  FACTORS  IN  RESPONDER  MICE 
TABLE  III 
Phenotypic Analysis of GA T-TsFR Cells 
Experi-  Treatment*  Added T cells:~ 
ment 
Day-5 IgG GAT- 
specific  PFC/ 
culture§ 
B 10 spleen cells 
BI0.B  BI0 
R  GAT-  GAT- 
M~  M~ 
None  Control  537  387 
None  Treated  67  360 
Anti-Lyt- 1 +  C  Treated  < 10  350 
Anti-Lyt-2 +  C  Treated  507  322 
Anti-Ars +  C  Treated  <10  315 
None  Control  498  340 
None  Treated  20  303 
Anti-I-J  k +  C  Treated  <10  363 
Anti-I-J  b +  C  Treated  508  320 
Anti-LA  d  Treated  < 10  288 
Anti-LA  b  Treated  20  328 
None  Control  678  508 
None  Treated  53  443 
Lyt- 1-  Treated  58  515 
Lyt- 1  +  Treated  545  550 
* Nonadherent T  cells recovered from R~MIg plates were treated with arsi- 
nilate-conjugated anti-Lyt-1 or anti-Lyt-2 antibody followed  by anti-Ars + 
C,  anti-Ars  +  C,  or  anti-I-J or  anti-I-A antibodies  +  C  (Materials  and 
Methods) before addition of 105 cells  to cultures (experiments 1 and 2). T 
cells nonadherent to RaMIg plates on the basis of adherence to plates coated 
with goat anti-rat immunoglobulin; l0  s cells nonadherent cells (Lyt-1) and 
adherent cells (Lyt-1 +) were added to culture (experiment 3). 
:~ Control, T  cells from B10 mice injected as neonates with B10-M@; treated, 
T cells from B 10 mice injected with B 10 GAT-Mq~ as neonates. 
§ B10 spleen cells (5 ×  10  n) were cultured with 3 X 104 GAT-Mq~ that bore 4- 
5 ng GAT/10  ~ cells from the indicated strains. 
responses to SRBC.  The  activated Ts cells, which had no effect when  added  at 36 and 
48  h  (Table  IV), suppressed  PFC  responses to GAT  when  added  at  the initiation of 
independent  cultures. 
GAT-TsR  were  unable  to suppress  secondary  PFC  responses to GAT  under  condi- 
tions  where  significant  suppression  of  primary  GAT-specific  PFC  responses  was 
demonstrated.  The  addition  of  GAT-TsR  to  cultures  of  spleen  cells  from  mice 
immunized  14  d  previously  with  10/~g GAT  failed  to  suppress  responses  stimulated 
with  B10  GAT-M~,  whereas  these  cells  suppressed  responses  by  virgin  B10  spleen 
cells in a  restricted manner  (Table V). Spleen cells from mice injected  14 d  previously 
with GAT  were considered  to be primed,  as evidenced  by their preferential  restimu- 
lation  by  B10  GAT-M~  and  absence  of significant  responses  to  GAT  presented  on 
allogeneic B 10.BR  M~,  as has previously been described  (7). 
Genetic Restrictions Regulating  GAT-spec~c  Suppression.  Genetic  restrictions  in  the CRAIG M.  SORENSEN AND CARL W.  PIERCE  1697 
TABLE IV 
Kinetics of Suppression by GA T-TSR Cells 
Time of addi- 
tion of GAT-Ts 
cells 
GAT-M~ 
Day-5 IgG PFC/culture 
SRBC  GAT 
h 
0  B10.BR  3,390  383 
0  BI0  3,525  <10 
24  B10.BR  3,300  387 
24  B10  3,445  <I0 
36  B 10.BR  3,450  386 
36  B  10  3,420  290 
48  B  10.BR  3,440  428 
48  B  10  3,420  400 
T cells from neonatally treated B10 mice were incubated with 3 ×  104 BI0 or 
B10.BR GAT-Mq~  for 24 h and 10  ~  cells were added at the indicated times to 
cultures of 5 × 106 virgin B 10 spleen cells stimulated with 2/tg GAT or SRBC. 
TABLE V 
GA T-TsR Cells Are Unable to Suppress Secondary Responses to GA T 
Responder spleen cells*  T cells:~ 
Day-5 PFC/cuhure§ 
BI0  B10.BR 
GAT-  GAT- 
M~  M~ 
SRBC 
Control  Control  580  410  4,883 
Treated  50  440  5,003 
GAT-immune  Control  420  18  4,133 
Treated  515  30  4,195 
* Control, virgin B10 spleen cells; GAT-immune, spleen cells from B10 mice 
immunized 14 d earlier with 10 #g GAT in Maalox-pertussis. 
Nylon wool-nonadherent T cells from control BI0 mice injected with BI0- 
M~b as neonates or treated B10 mice injected with B10 GAT-M~b  as neonates. 
§ B10 spleen cells (5 ×  10  r) were cultured with 10  s control or treated B10 T 
cells and 3 ×  104 of the indicated GAT-Mq~  that bore 3-4 ng GAT/10  s cells. 
activation of GAT-TsR cells from B10 mice treated as neonates with B10 GAT-Mq~ 
were  examined.  Significant suppression was  observed  after  activation of GAT-TsR 
with  B10  GAT-M~  and  B10.A(5R)  GAT-Mg,,  but  not  after  stimulation  with 
B10.AOR) GAT-Mth (Table VI). Thus, activation of GAT-TsR cells required stimu- 
lation with GAT presented on M~b syngeneic with the Ts cell at the K,I-A subregions 
of H-2. GAT-TsR cells from neonatally treated B 10 mice suppressed primary GAT- 
specific  PFC  responses  by  B10,  B10.A(3R),  and  B10.A(4R)  spleen  cells,  but  not 
responses by BI0.D2 or B10.A(5R) spleen cells (Table VII). These results indicated 
that syngeneity at the I-J subregion between the GAT-TsR cell and its target cell was 
necessary and sufficient for suppression. Furthermore, the ability to suppress appar- 
ently did  not  require homozygosity in  the  I-J  subregion: responses by  (B10.D2  × 
B 10)F1 spleen ceils were effectively suppressed by B 10 GAT-TsR cells (Table VII). 
Demonstration  of GA T-TsFR in Responder  Mice.  Supernatant fluids from spleen cells 
of B 10 mice neonatally injected with B 10 GAT-Mth, when cultured with 3 ×  104 B 10 
GAT-Mq~ for 24 h, profoundly suppressed primary PFC responses by B 10 spleen cells 1698  SUPPRESSOR  T  CELLS  AND  FACTORS  IN  RESPONDER  MICE 
TABLE  VI 
Genetic Requirements for Activation of GA T- Tsn Cells 
GAT-MqS*  Shared H-2 regions:~ 
Day-5 IgG GAT-spe- 
cific PFC/cuhure§ 
T  cellsll 
Control  Treated 
Bl0  KABJECSGD  605  <10 
BI0.A(5R)  KAB  583  90 
B 10.A(4R)  BJ E C S G D  568  522 
BI0.D2  None  505  515 
* 3 ×  10  4 GAT-Mq~/culture bearing ~3  4 ng GAT/10  ~ cells. 
:~ H-2 regions shared between stimulating GAT-M~b and the Ts cell. 
§ B10 spleen cells  (5 ×  10  6) were cultured with the indicated GAT-M~ and 
10  5 control or neonatally treated BI0 T cells. 
II Control, BI0  mice  injected with  BI0 M~ as  neonates; treated,  BI0  mice 
injected with B10 GAT-Mff as neonates. 
TABLE  VII 
Genetic Restrictions on GA T-Tsn Cell Activity 
Responder spleen cells  Shared H-2 regions* 
Day-5 PFC/culture:~ 
T cells§ 
Control  Treated  SRBC 
B10  KABJECSGD  533  28  2,110 
B 10.A(3R)  K A BJ  465  40  3,910 
B10.A(4R)  BJECSGD  418  60  3,400 
B 10.A  (5R)  K A B  493  433  2,310 
B 10.D2  None  440  453  2,800 
(B10.D2  ×  B10)F,  KABJECSGD  572  100  2,970 
* H-2 regions shared between the GAT-TsR cells and the responder spleen cells. 
:~ Responder spleen cells (5 X 106) from the indicated strain were cultured with 3 ×  104 B10 GAT-M~b and 
105 control or treated B10 T  cells;  IgG GAT-specific PFC/culture were assayed on day  5.  In control 
cultures, IgM PFC responses  to SRBC were assayed on day 5 in cultures of responder spleen cells and 105 
treated T cells stimulated with 3 X 104 B10 GAT-Mdp and 107 SRBC. 
§ Control, B10 mice injected with B10 M4~ as neonates; treated, B10 mice injected with B10 GAT-M~ as 
neonates. 
to GAT, but not to SRBC  (Fig.  1; Table VIII). Significant activity (~60% suppression) 
was  detected  at  final dilutions of 1:2,000  in culture;  the suppression observed  varied 
slightly with  preparations  of conventional  GAT-TsFR.  Supernatant  fluids  from  neo- 
natally  treated  B10  cells,  cultured  with  B10.D2  GAT-M~b  (Fig.  1),  or  from  control 
B10 cells, cultured  with either B10 or B10.D2  GAT-Mdp,  failed to suppress  responses 
by  B10  spleen  cells  at  all  concentrations  tested  (data  not  shown).  No  differences  in 
cell  numbers  or  cell  viability  was  observed  in  cultures  containing  control  or  active 
suppressor factors. 
T  cell hybridomas  that produce  GAT-TsFR  on a  constitutive basis were constructed 
to  allow  purification  and  biochemical  analysis  and  comparison  with  nonresponder 
GAT-TsF  (13). Activated GAT-TsR cells were fused with the AKR  thymoma  BW5147; 
supernatant  fluids  from  two  cloned  hybridomas,  372.B3.5  and  372.D6.5,  suppressed CRAIG  M.  SORENSEN  AND  CARL  W.  PIERCE  1699 
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FE¢.  1.  Effects of GAT-TsFR on primary GAT-specific PFC responses in vitro. Conventional (0), 
hybridoma 372.B3.5  (A)  and  372.D6.5  (A)  GAT-TsFR,  control supernatant  fluid  (activated by 
B10.D2 GAT-M~b) (O), and fluid from a negative fusion well 372.B3.6  (O--O) were tested at various 
dilutions for their ability to suppress PFC responses by normal B10 spleen cells (5 ×  106) stimulated 
with 2 ~g GAT. IgG-GAT-specific PFC/eulture were determined on day 5. GAT-specific response 
in absence of factor was 490 PFC/culture. 
TABLE  VIII 
Effects of GA T- TsFR on In  Vitro PFC Responses 
]P  n  ~ 
~xver'-  B 10 Spleen cells  Source of GAT-TsFR 
ment 
Day 5-PFG responses 
GAT  SRBC 
Virgin  372.B3.6  (control)  373  1,595 
Virgin  Conventional  53  1,613 
Virgin  372.D6.5  < 10  1,885 
Virgin  372,B3.5  38  1,830 
GAT-immune  372.B3.6  (control)  525  1,860 
GAT-immune  Conventional  495  1,875 
GAT-immune  372.D6.5  560  1,725 
GAT-immune  372.B3.5  535  1,613 
GAT- 
GAT  SRBC 
MBSA 
Virgin  372.B3.6  (control)  385  368  2,500 
Virgin  Conventional  33  35  2,750 
Virgin  372. D6.5  23  25  2,800 
Virgin  372.B3.5  35  83  3,780 
Spleen cells  (5 ×  10  ~) from virgin B10 mice or B10 mice immunized 3 wk previously with 10/.tg GAT in 
Maalox-pertussis were cultured with either 2/tg GAT, GAT-MBSA containing 2 #g GAT, or  107 SRBC 
and conventional GAT-TsFR (1:500 final dilution), hybridoma 372.D6.5  or 372.B3.5  GAT-TsFR (1:20,000 
final dilution), or control hybridoma fluid 372.B3.6  (1:10 final dilution). Data are expressed as IgG GAT- 
specific PFC  in cultures stimulated with GAT or GAT-MBSA and IgM  PFC  vs.  SRBC.  GAT-speeific 
response in the absence of factor was 390 PFG/cuhure for virgin spleen cells  and 500  PFC/euhure for 
immune spleen cells. 
primary  GAT-specific PFC  responses by B10 spleen cells by 50% at final dilutions of 
1:2,000,000  to  1:6,000,000  (Fig.  1).  Supernatant  fluids  from  BW5147  and  other 
hybridomas  (e.g., 372.B3.6)  from the same fusion were negative for GAT-TsFR  activity 
and  failed  to  suppress  at  final  dilutions  of  l:1000--the  lowest  dilution  tested.  All 
hybridoma  culture  supernatant  fluids  failed  to  suppress  responses  to  SRBC  (Table 
VIII). 
Parameters of GA T- TsFR-me&~zted Suppression.  Conventional  and  hybridoma-derived 1700  SUPPRESSOR  T  CELLS ANt)  FACTORS  IN RESPONDER  MICE 
GAT-TsFR  suppressed  primary  in  vitro  GAT-specific  PFC  responses  to  GAT  and 
GAT-MBSA,  but  not  PFC  responses  to  SRBC  by  B10  spleen  cells  (Table  VIII). 
Secondary  responses  to  GAT  were  not  suppressed  by either  hybridoma-derived  or 
conventional GAT-TsFR.  Kinetic  analysis of GAT-TsFR-mediated  suppression  dem- 
onstrated  that  hybridoma-derived  and  conventional  GAT-TsFR  had  to  be  present 
during the  first  24 h  of culture  for significant  suppression  to occur (Fig.  2 A). GAT- 
TSFR blocked initiation of the GAT-specific PFC response rather than causing a delay 
in the  response, because responses on days 6  and  7 were also completely suppressed 
(Fig. 2 B). 
Genetic  Restrictions  on  GA T-TsFR  Activity.  Production  of conventional  GAT-TsFR 
required  compatibility  at  the  K,I-A subregions  of H-2  between  the  GAT-M4~ and 
GAT-TsR cells, as previously shown for activation of the GAT-TsR cells  (Table VI). 
Genetic restrictions on the activity of GAT-TsFR at the level of interaction with target 
cells  was  examined  using  B10  congenic  mice  sharing  portions  of the  H-2  complex 
with the cell producing GAT-TsFR (Table IX). Conventional GAT-TsFR and hybrid- 
oma  372.D6.5  GAT-TsFR  suppressed  GAT-specific  PFC  responses  by  B10  and 
BI0.A(3R)  spleen  cells,  but  failed  to  suppress  responses  by  B10.D2  or  B10.A(5R) 
spleen  cells.  These results  demonstrate  a  restriction  mapping to the I-J subregion of 
H-2  to  obtain  suppression  with  hybridoma  372.D6.5  or  conventional  GAT-TsFR. 
Analysis of suppression by hybridoma 372.B3.5  GAT-TsFR demonstrated  no genetic 
restrictions  in  activity,  as  the  responses  to  GAT  by  all  tested  spleen  cells  were 
suppressed  to comparable degrees.  Lastly, the responses of (B10 ×  B 10.D2)Fa spleen 
cells were suppressed by all three sources of GAT-TsFR, and responses to SRBC were 
not significantly affected. 
Initial Characterization  of Conventional B l O and Hybridoma-derived  GA T- TsFR.  Apparent 
molecular  weights  of conventional  and  hybridoma-derived  GAT-TsFR  were  deter- 
mined  by  gel  filtration  on  a  Sephacryl  S-200  column  equilibrated  with  isotonic 
phosphate  buffer,  pH  7.2.  The  specific  suppressive  activity  of conventional  and 
hybridoma  372.B3.5  and  372.D6.5  GAT-TsFR eluted  between  the  marker  proteins 
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Fro.  2.  Kinetics  of GAT-TsFR-mediated suppression. BI0 spleen cells (5 ×  106) were cultured with 
2 #g GAT with conventional GAT-TsFR (0)  (1:500 final dilution), hybridoma  372.D6.5 (A) or 
372.B3.5 (A) GAT-TsFR (1:20,000 final dilution), or control hybridoma 372.B3.6 supernatant fluids 
(O--O)  (1:10, final dilution). GAT-TsFR were added  at  the  indicated  times; IgG GAT-specific 
PFC/culture  were determined on day 5 (A). IgG GAT-specific PFC/cuhure were determined on 
the indicated days in cultures receiving GAT-TsFn on day 0 (B). GAT-specific response in the 
absence of factor was 510 PFC/cuhure. CRAIG M.  SORENSEN AND CARL W.  PIERCE  1701 
TABLE  IX 
Genetic Restrictions  on GA T-TsFR Activity 
Shared H-2  Spleen cells  Source of GAT-TsF~  regions 
Day-5 PFC/culture 
GAT  SRBC 
B  10  None  All  435  1,550 
B  10  Conventional  All  28  1,975 
B 10  372.D6.5  All  63  2,110 
B10  372.B3.5  All  38  2,120 
B 10.A(3R)  None  K A BJ  455  1,910 
B  10.A(3R)  Conventional  K A BJ  30  1,720 
B 10.A(3R)  372.D6.5  K A BJ  33  2,980 
B 10.A(3R)  372.B3.5  K A BJ  50  2,310 
B 10.A(5R)  None  K A B  390  1,810 
B 10.A  (5R)  Conventional  K A B  403  1,755 
B10.A(5R)  372.D6.5  KAB  385  2,010 
B 10.A(5R)  372.B3.5  KA B  13  2,970 
B  10.D2  None  None  425  2,000 
B  10.D2  Conventional  None  418  1,950 
B 10.D2  372.D6.5  None  488  2,800 
B10.D2  372.B3.5  None  45  2,610 
(B10 × B10.D2)F1  None  All  525  1,430 
(B10 × B10.D2)F1  Conventional  All  100  1,650 
(B10 × B10.D2)F1  372.D6.5  All  <10  1,815 
(B10 X B10.D2)F1  372.B3.5  All  <10  1,980 
Spleen cells (5 ×  106) from the indicated strains of mice were cultured with 2 ~g GAT or 10  v SRBC and 
conventional GAT-TsFR (1:500 final dilution) or hybridoma 372.D6.5- or 372.B3.5-derived GAT-TsFrt 
(1:20,000 final dilution). IgG GAT-specific  and IgM vs. SRBC PFC/culture  were determined on day 5. 
The  H-2  regions shared between the  cells producing GAT-TsF~ and  the  responder spleen cells are 
indicated. 
BSA and ovalbumin (OVA),  thus placing the  apparent  molecular weight  between 
48,000 and 63,000  (Fig. 3). Activity of all three GAT-TsFR was totally destroyed by 
exposure to trypsin and to a  pH of 2.0 or 3.0 and was partially destroyed by heating 
to 50°C for 30 min (data not shown). 
Conventional and hybridoma-derived GAT-TsFR from B 10 mice were absorbed by 
immunoadsorbents  composed  of  B10.D2  anti-B10  (anti-H-2b),  B10.A(5R)  anti- 
B 10.A(3R) (anti-J  b) alloantisera, and the monoclonal WF9.40.5 (anti-J  b) reagent, but 
not  by immunoadsorbents composed  of (B10.A  ×  A)  anti-B10.A(5R)  (anti-KABb), 
(BI0.A  ×  BI0)  anti-B10.D2  (anti-KABJE)  d,  [A.TL  ×  B10.S(9R)]  anti-B10.HTT 
(anti-J  s)  alloantisera, or the monoclonal WF8.C12.8 (anti-J  k)  reagent  (Table X).  In 
all cases activity bound to the immunoadsorbents could be eluted quantitatively with 
2.0  M  KCI  (data  not  shown).  These  findings  demonstrate  the  presence  of  I-J  b 
determinants on the three GAT-TsFR. RaMIg or rabbit anti-GAT immunoabsorbents 
failed to remove significant suppressive activity from GAT-TsFR. 
The  three  GAT-TsFR were  also  analyzed for  antigen-binding capacity  and  fine 
specificity by their ability to bind to immunoadsorbents  composed of different proteins 
or polypeptides related to GAT. Suppressive activity was retained by immunoadsorb- 1702  SUPPRESSOR  T  CELLS  AND  FACTORS IN  RESPONDER  MICE 
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Fie.  3.  Molecular  weight  of GAT-TsFR by  gel  filtration.  Conventional  GAT-TsF]~ (0)  (A), 
hybridoma 372.B3.5 (&) (B), and 372.D6.5 (A) (C) GAT-TsFIt after chromatography  on a Sephacryl 
S-200 column with phosphate buffer were assayed for ability to suppress a primary response to GAT 
by BI0 spleen cells. Data are expressed as the percentage  of suppression of GAT-specifie PFC 
response, which was 525 PFC/culture in control cultures. Arrows indicate the fractions where the 
marker proteins BSA, OVA, and cytochrome c (Cyt C) eluted; OD at 280 nm (O). 
ents composed of GAT and the related polymer, GT, but not by immunoadsorbents 
composed of GA or BSA  (Table X).  Suppressive activity could be eluted from GAT 
and GT immunoadsorbents with  2.0 M  KC1.  The GAT-TsFR were analyzed for the 
presence of idiotype determinants shared with murine anti-GAT antibodies (21). The 
anti-idiotype immunoadsorbent anti-cGAT quantitatively removed suppressor activ- 
ity  (Table  X),  which  could  be  recovered  after  elution  with  2.0  M  KCI.  Finally, 
suppressive  activity  was  also  absorbed  by  PNA  agarose,  showing  the  presence  of 
carbohydrate moieties on the three species of GAT-TsFR. 
Discussion 
Adult spleen cells from  B 10  mice injected intravenously with syngeneic GAT-M~ 
within  18  h  of birth  failed to  develop significant GAT-specific PFC  responses after 
stimulation  with  soluble  GAT,  GAT-MBSA,  or  syngeneic  GAT-Mq);  responses  to 
allogeneic GAT-M~  and an  irrelevant antigen, SRBC,  were intact. The response to 
GAT presented on allogeneic Mq~ suggested that the B cell pool capable of generating 
anti-GAT antibody responses was intact and the selective inability to respond to GAT 
was  not  a  result  of a  B  cell defect.  The  cell responsible for the unresponsiveness  to 
syngeneic GAT-Mq~ was identified as Ts cell by showing that T  cells from neonatally 
treated  B10  mice  could  suppress  responses  to  GAT  by  virgin  B10  spleen  cells 
stimulated by B 10 GAT-Mqx The GAT-specific Ts cell from responder mice  (GAT- 
TsR cell) was sensitive to 500  rad irradiation, treatment  with  anti-Thy-1  -t- C,  anti- 
Lyt-2 +  C, and anti-I-J  b +  C, but was unaffected by treatment  with anti-Lyt-1 +  C 
or anti I-A  b +  C. Therefore, the phenotype of the GAT-TsR cell was Lyt-l-2  +, I-J  +. 
GAT-TsR  cells  had  to  be  present  within  the  first  24  h  of culture  for  significant 
suppression  to  occur.  Suppression  was  restricted  to  primary  GAT-specific PFC  re- CRAIG M.  SORENSEN AND CARL W.  PIERCE  1703 
TABLE  X 
Immunochemical Characterization of Conventional and Hybridoma-derived GA T- TsFR 
Control response 
Experiment  Immunoadsorbent  Conven-  372.D6.5  372.B3.5  tional 
GAT-TsFR  GAT-TsFR GAT-TsFR 
% 
None  9  4  8 
Anti-H-2  b  85  86  83 
Anti-J  b (alloantiserum)  92  88  94 
Anti-J  b (monoclonal)  82  91  87 
Anti-(KAB)  b  11  5  11 
Anti-(KABJE)  a  13  6  18 
Anti-J  s (alloantiserum)  3  5  3 
Anti-J  k (monoclonal)  5  3  5 
Anti-Ig  18  12  12 
Anti-GAT  15  10  10 
None  10  5  9 
GAT  99  112  112 
GT  88  119  128 
GA  9  11  6 
BSA  8  8  5 
Anti-cGAT  91  89  84 
PNA agarose  100  101  108 
Conventional and hybridoma-derived GAT-TsFR  were absorbed with the indicated 
immunoadsorbent before addition to culture at final dilutions of 1:500 (conventional 
GAT-TsFH) or  1:20,000 (hybridoma GAT-TsFa). BI0 spleen cells (5  X  106) were 
cultured with 2/*g GAT and GAT-TsF~ absorbed with the various immunoadsorb- 
ents; data are presented as percent control PFC response, which was 525 IgG GAT- 
specific PFC/culture in experiment  I and 625  IgG GAT-specific PFC/cuhure in 
experiment 2. 
sponses;  secondary  PFC  responses  to  GAT  were  resistant  to  GAT-TsR,  as  were 
responses  to  an  irrelevant antigen, SRBC.  These GAT-TsR cells were  activated by 
GAT presented on Mff syngeneic at K,I-A with the Ts cell; once activated, the action 
of GAT-TsR cells was restricted to target cells syngeneic at IoJ with the Ts cell. 
Restimulation of these  ceils with  B10  GAT-Mth resulted  in  the  production and 
secretion of a  suppressor factor that  functionally substituted for the GAT-Tsa cells 
into  the  supernatant fluid.  The  suppressor  factor,  GAT-TsFR, exhibited the  same 
genetic restrictions and kinetics of action, and affected the same range of responses as 
the  GAT-TsR cells.  T  cell  hybridomas  producing  GAT-TsFR were  generated  to 
facilitate characterization and purification. Initial characterization of conventional 
and two hybridoma-derived GAT-TsFR showed that  the GAT-TsFR were glycopro- 
teins with an apparent molecular weight between 48,000 and 63,000  whose activity 
was destroyed by trypsin, a pH of 3.0, and by heating to 50°C for 30 rain, suggesting 
that tertiary structure is required for activity. The three GAT-TsFa lacked detectable 
Ig-constant-region determinants, but  had  determinants recognized by  antisera di- 
rected  against the  common idiotype on anti-GAT antibodies (the  cGAT  idiotype) 
and had determinants encoded by the I-J subregion of the H-2 complex. The GAT- 
TsFR also were specifically absorbed by GAT and GT immunoadsorbents, but not by 1704  SUPPRESSOR T  CELLS AND FACTORS IN  RESPONDER MICE 
the closely related polymer GA. Of the two T  cell hybridomas that secrete GAT-TsFR 
on a constitutive basis, hybridoma 372.D6.5 GAT-TsFR was identical to conventional 
GAT-TsFR  in  activities  and  properties,  whereas  hybridoma  372.B3.5  GAT-TsFR 
differs from hybridoma 372.D6.5  and conventional GAT-TsF~ in genetic restrictions 
on interactions with target cells (see below). 
The  ability  to  generate  GAT-Ts  cells  in  responder  mice  has  been  previously 
demonstrated,  but only under certain circumstances  (4-6). The activation of GAT- 
specific, but  genetically unrestricted,  Ts cells has been suggested as the  mechanism 
responsible for the pattern of genetic restrictions observed in secondary responses to 
GAT by spleen cells from immune responder and (responder ×  nonresponder)F1 mice 
(6,  7,  22).  GAT-specific  Ts  cells  may  also  be  generated  in  vitro  by  exposure  of 
responder T  cells to GAT in the absence of Mq);  this result has been interpreted  to 
suggest  that  Mdp-bound  antigen  stimulates  helper T  cells,  whereas  soluble  antigen 
preferentially stimulates  Ts cells  (4).  The  induction  of GAT-TsR cells by neonatal 
injection  of syngeneic  GAT-M~  is,  to  our  knowledge,  the  first  demonstration  of 
induction  of Ts  cells  by  this  mechanism  and  appears  to  contradict  the  previous 
findings  of Pierres  and  Germain  (4).  The  precise  relationships  among  the  various 
GAT-specific Ts cells induced  in responder mice by these different regimens are not 
yet clear, but are currently under investigation. 
It  is  also  important  to  note  that  studies  similar  to  these  have been  reported  by 
Debr~  (5)  where  mice were  given an  intraperitoneal  injection  of GAT in  Maalox- 
pertussis  at  birth  and  were  examined  for suppressor  activity  later  in  neonatal  life 
rather than as adults; Ts cells could be induced in mice injected at birth, but not on 
day  8  or  after.  The  Ts cells  described  here  are  induced  within  24  h  of birth,  are 
phenotypically  stable  into  the  adult  life and  may be of the  same lineage  as  those 
described by Debr~. 
GAT-Ts cells from responder mice injected  as neonates with syngeneic GAT-MO 
and nonresponder mice injected as adults with soluble GAT have identical biological 
activity: both Ts cell populations suppress primary, but not secondary, PFC responses 
to GAT by spleen  cells from the  appropriate mouse strain(s)  in  an antigen-specific 
manner and with  identical  kinetics.  Important subtle differences, however, do exist 
between these two populations:  GAT-TsR ceils are induced  by antigen-pulsed synge- 
neic M~ or soluble antigen; nonresponder GAT-Ts ceils are induced after injection of 
soluble antigen only. GAT-TsR cells are also initially stimulated in neonatal animals 
and require reactivation to function, whereas nonresponder GAT-Ts cells are stimu- 
lated directly in adult animals and do not exhibit memory (2, 3).  GAT-TsR cells are 
genetically restricted and require syngenicity at the I-J subregion between the Ts cell 
and target cell to achieve suppression; similar experiments with nonresponder GAT- 
Ts cells have not been carried out to determine if these cells require syngenicity at the 
I-J subregion to suppress. The ability of GAT-Ts cells, but not nonresponder GAT-Ts 
cells,  to  suppress  responses  by  appropriate  F1  spleen  cells  may  suggest  different 
mechanisms of suppression in responder and nonresponder mice to GAT. This would 
predict a  minimum of two similar (although  unique  and probably parallel)  mecha- 
nisms for regulating a specific immune response. An alternative possibility is that the 
two GAT-Ts cells represent  different  cells along a  hypothetical common suppressor 
pathway similar to that  suggested by Germain and  Benacerraf (23),  implying that 
although  the  mechanism of suppression  may be the same in  responder and  nonre- CRAIG M.  SORENSEN AND CARL W.  PIERCE  1705 
sponder mice, the point of entry into the suppressor pathway is different. 
These GAT-TsR cells mediate suppression  via  a  soluble suppressor factor, GAT- 
TsFR, which can substitute for the Ts cell. Antigen-specific suppressor factors derived 
from Ts cells have been demonstrated in a  number of different systems (23-25) and 
those from nonresponder Ts cells have been well-characterized in the GAT system (8- 
13).  The nonresponder GAT-specific suppressor  factor GAT-TsF is  a  glycoprotein, 
originally extracted from Ts cells from nonresponder mice immunized with soluble 
GAT, and more recently produced by T  cell hybridomas on a constitutive basis; the 
hybridoma-derived product  is  indistinguishable  from  the  conventionally extracted 
GAT-TsF (12,  13). GAT-TsF from hybridoma 258.C4.4 has a binding site for GAT, 
shares determinants from the Ig-variable region with anti-GAT antibodies (i.e., bears 
the cGAT idiotype) and bears determinants encoded by the I-J subregion of the H-2 
complex. The glycoprotein has a molecular weight of 24,000 and has been extensively 
characterized in terms of its immunochemical properties and range of activities (8- 
13). 
The conventional and hybridoma-derived GAT-TsFR described here share many 
characteristics with nonresponder GAT-TsF. For example, determinants encoded by 
the I-J subregion of the strain  producing the suppressor factors have been demon- 
strated on GAT-TsF and the three species of GAT-TsFR; relatively crude preparations 
of GAT-TsF and GAT-TsFR have similar molecular weights when determined by gel 
filtration methods using physiologic buffers. When the molecular weight of GAT-TsF 
from hybridoma 258.C4.4 was  initially determined by Sephacryl S-200 chromatog- 
raphy, it was in the 48,000-63,000 range. However, the 24,000 mol wt was determined 
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis after extensive purifi- 
cation on high-pressure liquid chromatography resins in high-ionic-strength buffers 
(13). Preliminary purification of GAT-TsFR from hybridomas 372.B3.5 and 372.D6.5 
in isotonic buffers indicated molecular weights in the 48,000-63,000 range. Purifica- 
tion  in  high-ionic-strength  buffers  (0.5  M  acetic  acid;  1  M  pyridine)  by  high- 
performance liquid  chromatographic procedures indicates  the molecular weight  of 
GAT-TsFg from hybridoma 372.B3.5 is 24,000, whereas GAT-TsFR from hybridoma 
372.D6.5  has  a  60,000  mol wt  (26;  and  C.  M.  Sorensen, Pierce, C.  W.,  and  D.  R. 
Webb, manuscript in preparation). GAT-TsF and GAT-TsFR bind to GAT and bear 
the  cGAT idiotypic determinants;  as  determined  by the  ability of the  anti-cGAT 
idiotypic reagent, produced in guinea pigs immunized with affinity-purified serum 
anti-GAT antibodies  (21), to absorb nonresponder GAT-TsF (27)  and  the conven- 
tional  and  the  two species of hybridoma responder GAT-TsFR. Thus,  the  various 
GAT-specific suppressor factors could bear the  identical  idiotypic determinant  ex- 
pressed on antibody to GAT, or at least bear a determinant that is cross-reactive. The 
purification of hybridoma-derived GAT-TsF and GAT-TsFR and a detailed compar- 
ison with monoclonal anti-GAT antibodies should resolve this issue. Lastly, GAT-TsF 
and GAT-TsFR suppress primary GAT-specific PFC responses in an antigen-specific 
manner and also suppress GAT-specific T  cell-proliferative responses (11;  and C. M. 
Sorensen and C. W. Pierce, unpublished observations). 
Although  the  GAT-TsFR  and  nonresponder  GAT-TsF  have  characteristics  in 
common,  important  differences  exist.  The  differences  in  molecular  weights  after 
purification in high-ionic-strength buffers noted above and in genetic restrictions at 
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currently noted between the two hybridoma-derived GAT-TsFR and conventional or 
hybridoma-derived  nonresponder  GAT-TsF.  Conventional  GAT-TsF  derived  from 
one  nonresponder  strain  (DBA/1,  H-2  q)  suppressed  PFC  and  T  cell-proliferative 
responses to GAT by other nonresponder strains in an antigen-specific manner (9,  11, 
28). The hybridoma 258.C4.4 GAT-TsF, derived from DBA/1 Ts cells, also suppresses 
PFC  and  proliferative responses  to  GAT by other  nonresponder  strains  (12).  This 
same pattern of unrestricted suppression has been observed with hybridoma 372.B3.5 
GAT-TsFR, which suppressed PFC responses by spleen cells from all H-2 haplotypes 
tested in an antigen-specific manner.  Recent preliminary experiments demonstrated 
that  hybridoma  258.C4.4  GAT-TsF and hybridoma 372.B3.5  GAT-TsF•  cross-sup- 
pressed GAT-specific PFC responses of nonresponder spleen cells to GAT-MBSA and 
responder  spleen  cells  to  GAT  (C.  W.  Pierce,  J.  A.  Kapp,  and  C.  M.  Sorensen, 
unpublished observations). Thus, these two species of GAT-specific suppressor factors, 
258.C4.4 GAT-TsF and 372.B3.5  GAT-TsFR, appear to represent one class of factors 
that suppressd PFC and/or proliferative responses in a genetically unrestricted manner 
and  have  a  molecular  weight  of  24,000  after  purification  by  high-ionic-strength 
buffers and high-pressure liquid chromatography (13,  26; and C. M. Sorensen, C. W. 
Pierce, and D. R. Webb, manuscript in preparation). 
By contrast,  conventional  GAT-TsFR and  hybridoma  372.D6.5  GAT-TsFR only 
suppress PFC responses by spleen cells from mice bearing the I-J  b haplotype. These 
GAT-TsFR appear to represent a  second class of factors that suppress responses in a 
genetically restricted  manner.  Because the conventional  GAT-TsFR and hybridoma 
372.D6.5  GAT-TsFR are  identical  in  all  respects  tested  to  date,  it  is  reasonable  to 
conclude that the GAT-TsR cell producing conventional GAT-TsFR has been immor- 
talized in hybridoma 372.D6.5. Thus far we have not detected activity comparable to 
hybridoma 372.B3.5  GAT-TsFR in conventional GAT-TsFR preparations.  Although 
syngenicity at  the I-J subregion is necessary and sufficient  for suppression  by these 
two species of GAT-TsFR, homozygosity at the I-J subregion is not required, because 
responses by spleen cells from (B10  X  B10.D2)F1  mice, which  are  (I-J  b x  I-Jd)F1 at 
I-J, are suppressed to a  degree comparable to responses by spleen cells from a  I-J  b 
homozygote such as B10.  The ability to suppress responses by F1 mice has not been 
demonstrated  for nonresponder  GAT-TsF unless  both  parents  in  the  F1  are nonre- 
sponder haplotypes (9). 
The  two  hybridoma-derived  GAT-TsFR  described  were  derived  from  the  same 
population  of GAT-TsR cells,  yet  may represent  fusions  of unique  populations  of 
GAT-TsR cells. Hybridoma 372.D6.5 GAT-TsFR is genetically restricted in action by 
the I-J subregion, whereas hybridoma 372.B3.5 GAT-TsFR is genetically unrestricted, 
which is analogous to nonresponder GAT-TsF. These two hybridoma-derived GAT- 
TsFR are, in many respects, similar to other Ts cell factors that may be divided into 
two broad categories: one type of TsF is I-J  + and acts in an unrestricted  manner;  a 
second type of TsF is also I-J  + but acts in a genetically restricted manner (15, 24, 25, 
29). 
Suppressor factors with properties of the first group, referred to as TsF1 in the GAT 
system  (26),  have  been  detected  after injection  of syngeneic  cells  derivatized  with 
haptens, such as azobenzene arsonate (ABA) (30)  and 4-hydroxy-3-nitrophenyl acetyl 
(NP)  (31), injection of nonresponder mice with GAT (8-13), or injection of mice with 
the copolymer GT  (29).  Hybridoma 372.B3.5  GAT-TsFR and  hybridoma  258.C4.4 CRAIG  M.  SORENSEN  AND  CARL  W.  PIERCE  1707 
are representative of TsF1. These TsF1 factors are products of Ts cells that appear to 
be activated early in the suppressor pathway (23-25, 29); these Ts cells and their TsF1 
products are essential  for the  induction  of a  second-order of Ts cells that  produce 
suppressor factors, termed TsF2 in the GAT-system. Hybridoma 372.D6.5 GAT-TsFR 
is  representative of a  TsF2  in  the  GAT-system.  TsF2  are  distinguished  from  TsF1 
primarily by the genetic restrictions on their activity, although differences in molecular 
weights and number of polypeptide chains are beginning to emerge as these molecules 
are  further  characterized  (26;  C.  M.  Sorensen,  C.  W.  Pierce,  and  D.  R.  Webb, 
manuscript in preparation). The TsF to be detected in the NP (31, 32) and ABA (25, 
30, 33) systems (and called TsF2 in these systems) are in fact anti-idiotype in reactivity, 
and are idiotype negative, non-antigen binding,  and are induced in  the absence of 
antigen. In the GT system, however, TsF1 alone does not induce a species of TsF2, but 
TsF1 plus GT induces TsF2, which has antigen-binding specificity for GT (29). The 
GT-TsF2 and hybridoma 372.D6.5 GAT-TsFR have many similarities with the carrier- 
specific,  I-J+-region-restricted suppressor  factors described by Tada  and  Okumura 
(24) and Taniguchi et al. (34). One possible and intriguing interpretation of our data 
is that  the two hybridomas, 372.B3.5 and 372.D6.5, represent sequential cells along 
the GAT-suppressor pathway. It is not known how these two distinct GAT-TsR cells 
were activated by injection of GAT-Mq~ into neonates. The precise location of these 
two GAT-TsFR along the GAT suppressor pathway, the biochemical and functional 
relationships between responder and nonresponder GAT-TsF species, and the analysis 
of the mechanism(s) of suppression are currently being investigated. 
Summary 
Spleen cells from C57B1/10 mice injected with syngeneic B 10 L-glutamic acid6°-L - 
alanine3°-L-tyrosine  1°  (GAT)-pulsed macrophages  (GAT-M~)  within  18  h  of birth 
were unable to respond to soluble GAT, GAT-methylated bovine serum albumin, or 
B 10 GAT-M~ as adults. Spleen cells from these neonatally treated mice responded at 
control levels to GAT presented in allogeneic Mq~ and to sheep erythrocytes. Partially 
purified T  cells from these neonatally treated mice suppressed responses by syngeneic 
virgin, but not primed, spleen cells in an antigen-specific manner and acted during 
the early phases  of the  response.  These responder GAT-specific suppressor T  cells 
(GAT-TsR) were sensitive to anti-Thy-1  +  C  and 500-rad irradiation and have the 
phenotype Ly-l-2  +, I-J+; GAT-TsR cells can only suppress responses by spleen cells 
syngeneic with the GAT-TsR cells at the I-J subregion of H-2. Restimulation of these 
Ts cells with syngeneic GAT-Mq~ induces an antigen-specific suppressor factor within 
the  supernatant  fluid.  The  factor, GAT-TsFR,  is  a  glycoprotein with  a  molecular 
weight between 48,000 and 63,000, as determined by gel filtration chromatography 
using isotonic buffers; it bears serologically detectable determinants encoded by the 
I-J subregion of the H-2 complex, has an antigen-binding site for GAT and L-glutamic 
acidS°-L-tyrosine  ~°, and shares idiotypic determinants with anti-GAT antibodies. The 
presence of GAT-TsFR in the first 36 h  of in vitro culture is required for significant 
suppression.  Furthermore,  only  responses  by  spleen  cell  syngeneic  with  the  cells 
producing GAT-TsFR at the I-J subregion are suppressed. The fusion of GAT-TsFR- 
producing cells with BW5147 resulted in generation of two hybridomas with properties 
and characteristics identical to those of the conventional GAT-TsFR with one excep- 
tion:  conventional and  hybridoma 372.D6.5  GAT-TsFR only suppress responses by 1708  SUPPRESSOR  T  CEI,LS  AND  FACTORS IN  RESPONDER  MICE 
spleen  cells  of  the  I-J  b  haplotype,  whereas  suppression  mediated  by  the  second 
hybridoma GAT-TsFR (372.B3.5)  is genetically unrestricted. These hybridoma GAT- 
TsFR are compared with nonresponder GAT-Ts factor (GAT-TsF) and these responder 
and nonresponder GAT-TsF are considered in the context of suppressor pathways. 
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